A Phase 1 Study of the Combination of MG4101, Ex Vivo-Expanded Allogeneic NK Cells and Rituximab for Relapsed or Refractory Non-Hodgkin Lymphoma

被引：8
|
作者：
Yoon, Dok Hyun
Koh, Youngil
Park, Heesook
Hwang, Yu Kyeong
Kim, Won Seog
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-133518
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Phase I Study: Safety and Efficacy of an Ex Vivo-Expanded Allogeneic Natural Killer Cell (MG4101) with Rituximab for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma
    Yoon, Dok Hyun
    Koh, Youngil
    Jung, Miyoung
    Kwak, Jeong-Eun
    Shin, Eui-Cheol
    Hwang, Yu Kyeong
    Kim, Won Seog
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (04): : 253e1 - 253e9
  • [2] EFFECT OF MG4101, RANDOM DONOR DERIVED, EX VIVO-EXPANDED NK CELLS, IN COMBINATION WITH RITUXIMAB IN B CELL LYMPHOMA MODEL
    Her, J.
    Lee, E.
    Gwon, S.
    Cho, S.
    Hwang, Y.
    CYTOTHERAPY, 2017, 19 (05) : S37 - S37
  • [3] Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial
    Kambhampati, Swetha
    Fakhri, Bita
    Ai, Weiyun Z.
    Kaplan, Lawrence D.
    Tuscano, Joseph M.
    Wieduwilt, Matthew J.
    Sudhindra, Akshay
    Cavallone, Erika
    Reiner, Jesika
    Aoun, Charlie
    Castillo, Miguel
    Martinelli, Michelle
    Ta, Teresa
    Le, Diem
    Padilla, Michelle
    Crawford, Erika
    Andreadis, Charalambos B.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (03): : 139 - 146
  • [4] A phase I study of rituximab and buparlisib in patients with relapsed or refractory indolent non-Hodgkin lymphoma
    Bond, David A.
    Huang, Ying
    Christian, Beth A.
    Jaglowski, Samantha
    Benson, Don
    Alinari, Lapo
    Baiocchi, Robert A.
    Cohen, Jonathon B.
    Blum, Kristie A.
    Maddocks, Kami J.
    LEUKEMIA & LYMPHOMA, 2022, 63 (07) : 1750 - 1753
  • [5] ANALYSIS OF A PHASE 2 STUDY OF LENALIDOMIDE AND RITUXIMAB IN RELAPSED OR REFRACTORY NON-HODGKIN'S LYMPHOMA
    Dutia, M.
    DeRoock, I.
    Chee, K.
    O'Donnell, R.
    Quirch, C.
    Reed-Pease, C.
    Tuscano, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 118 - 118
  • [6] Combination antibody therapy with epratuzumab and rituximab in relapsed or refractory non-Hodgkin's lymphoma
    Leonard, JP
    Coleman, M
    Ketas, J
    Ashe, M
    Fiore, JM
    Furman, RR
    Niesvizky, R
    Shore, T
    Chadburn, A
    Horne, H
    Kovacs, J
    Ding, CL
    Wegener, WA
    Horak, ID
    Goldenberg, DM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) : 5044 - 5051
  • [7] Phase I Study of the Combination of Bendamustine, Rituximab, and Pixantrone in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
    Heyman, Benjamin
    Rizzieri, David
    Adams, David J.
    De Castro, Carlos
    Diehl, Louis
    Li, Zhiguo
    Moore, Joseph
    Beaven, Anne
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (10): : 679 - 686
  • [8] A phase II study of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed or refractory non-Hodgkin lymphoma
    Ikoma, Yoshikazu
    Nakamura, Nobuhiko
    Kitagawa, Junichi
    Miwa, Takao
    Takada, Eri
    Matsumoto, Takuro
    Shibata, Yuhei
    Nakamura, Hiroshi
    Kanemura, Nobuhiro
    Kasahara, Senji
    Hara, Takeshi
    Sawada, Michio
    Tsurumi, Hisashi
    Shimizu, Masahito
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (01)
  • [9] A Phase II Study of Gemcitabine, Rituximab, and Oxaliplatin In Combination for Relapsed/Refractory Non-Hodgkin's Lymphomas
    Cultrera, Jennifer L.
    Liu, Jijun
    Liboy, Idalia
    Bello, Celeste M.
    Sokol, Lubomir
    Sotomayor, Eduardo M.
    Santana, Enrique
    Cabanillas, Fernando
    BLOOD, 2010, 116 (21) : 1186 - 1186
  • [10] A phase 1/1b study of rituximab, bendamustine, and ibrutinib in patients with untreated and relapsed/refractory non-Hodgkin lymphoma
    Maddocks, Kami
    Christian, Beth
    Jaglowski, Samantha
    Flynn, Joseph
    Jones, Jeffery A.
    Porcu, Pierluigi
    Wei, Lai
    Jenkins, Cynthia
    Lozanski, Gerard
    Byrd, John C.
    Blum, Kristie A.
    BLOOD, 2015, 125 (02) : 242 - 248
12345